• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症VII型小鼠海马体蛋白质组和转录组变化的综合分析

Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.

作者信息

Parente Michael K, Rozen Ramona, Seeholzer Steven H, Wolfe John H

机构信息

Research Institute of the Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Research Institute of the Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; W. F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Mol Genet Metab. 2016 May;118(1):41-54. doi: 10.1016/j.ymgme.2016.03.003. Epub 2016 Mar 7.

DOI:10.1016/j.ymgme.2016.03.003
PMID:27053151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4832927/
Abstract

Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the deficiency of β-glucuronidase. In this study, we compared the changes relative to normal littermates in the proteome and transcriptome of the hippocampus in the C57Bl/6 mouse model of MPS VII, which has well-documented histopathological and neurodegenerative changes. A completely different set of significant changes between normal and MPS VII littermates were found in each assay. Nevertheless, the functional annotation terms generated by the two methods showed agreement in many of the processes, which also corresponded to known pathology associated with the disease. Additionally, assay-specific changes were found, which in the proteomic analysis included mitochondria, energy generation, and cytoskeletal differences in the mutant, while the transcriptome differences included immune, vesicular, and extracellular matrix changes. In addition, the transcriptomic changes in the mutant hippocampus were concordant with those in a MPS VII mouse caused by the same mutation but on a different background inbred strain.

摘要

黏多糖贮积症VII型(MPS VII)是一种由β-葡萄糖醛酸酶缺乏引起的溶酶体贮积病。在本研究中,我们比较了MPS VII的C57Bl/6小鼠模型海马蛋白质组和转录组相对于正常同窝小鼠的变化,该模型具有充分记录的组织病理学和神经退行性变化。在每个检测中,正常小鼠和MPS VII同窝小鼠之间发现了完全不同的一组显著变化。然而,两种方法生成的功能注释术语在许多过程中显示出一致性,这也与该疾病相关的已知病理学相对应。此外,还发现了特定检测的变化,在蛋白质组分析中,突变体中的这些变化包括线粒体、能量产生和细胞骨架差异,而转录组差异包括免疫、囊泡和细胞外基质变化。此外,突变体海马中的转录组变化与由相同突变但背景不同的近交系引起的MPS VII小鼠中的变化一致。

相似文献

1
Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.黏多糖贮积症VII型小鼠海马体蛋白质组和转录组变化的综合分析
Mol Genet Metab. 2016 May;118(1):41-54. doi: 10.1016/j.ymgme.2016.03.003. Epub 2016 Mar 7.
2
Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.在黏多糖贮积症VII型小鼠模型中,短期酶替代治疗后肝脏中仍存在众多转录改变。
Biochem J. 2004 Apr 15;379(Pt 2):461-9. doi: 10.1042/BJ20031048.
3
Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase.用表达β-葡萄糖醛酸酶的1型单纯疱疹病毒载体对黏多糖贮积症VII型小鼠脑内的溶酶体贮积进行广泛校正。
Mol Ther. 2006 May;13(5):859-69. doi: 10.1016/j.ymthe.2005.12.017. Epub 2006 Mar 3.
4
Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.在小鼠黏多糖贮积症VII型神经祖细胞中异常量的糖胺聚糖积累不会改变其生长速率或向神经元分化的效率。
Mol Cell Neurosci. 2001 Jan;17(1):167-78. doi: 10.1006/mcne.2000.0917.
5
Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.活性位点突变转基因赋予对人β-葡萄糖醛酸酶的耐受性,而不影响黏多糖贮积症VII型小鼠的表型。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2205-10. doi: 10.1073/pnas.051623698. Epub 2001 Feb 13.
6
Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.在非致病性单纯疱疹病毒1型载体中,来自潜伏期相关转录启动子的β-葡萄糖醛酸酶在黏多糖贮积症VII型小鼠中枢神经系统中的表达显著增加。
Mol Ther. 2000 Jul;2(1):82-94. doi: 10.1006/mthe.2000.0093.
7
Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.对人源和鼠源β-葡萄糖醛酸酶具有双重耐受性的MPS VII小鼠(Gus(tm(hE540A x mE536A)Sly))的产生。
Hum Mol Genet. 2003 May 1;12(9):961-73. doi: 10.1093/hmg/ddg119.
8
Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.黏多糖贮积症VII型小鼠模型中溶酶体贮积病的早期发作:未降解的底物在胎儿和非常年幼的MPS VII小鼠的许多组织中积累。
Pediatr Dev Pathol. 2005 Jul-Aug;8(4):453-62. doi: 10.1007/s10024-005-0025-8. Epub 2005 Oct 12.
9
Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.犬β-葡萄糖醛酸酶cDNA的克隆、犬黏多糖贮积症VII型的突变鉴定以及逆转录病毒载体介导的黏多糖贮积症VII型细胞的校正
Genomics. 1998 Mar 1;48(2):248-53. doi: 10.1006/geno.1997.5189.
10
Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.在黏多糖贮积症VII型的gus(mps/mps)小鼠模型中,慢病毒介导的基因治疗可使β-葡萄糖醛酸酶持续表达长达12个月;在gus(tm(L175F)Sly)小鼠模型中则可持续表达长达18个月。
Hum Gene Ther. 2014 Sep;25(9):798-810. doi: 10.1089/hum.2013.141. Epub 2014 Aug 14.

引用本文的文献

1
Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA.黏多糖贮积症 IIIB 型和 IVA 型中表观遗传景观变化的证据。
Sci Rep. 2024 Feb 17;14(1):3961. doi: 10.1038/s41598-024-54626-4.
2
Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment.肌动蛋白细胞骨架聚合和黏着斑作为黏多糖贮积症发病机制中的重要因素及潜在治疗靶点。
Cells. 2023 Jul 5;12(13):1782. doi: 10.3390/cells12131782.
3
Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach.

本文引用的文献

1
Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.双侧单次脑内注射非致病性单纯疱疹病毒 1 载体可减少 MPS VII 小鼠的焦虑行为。
Mol Ther Methods Clin Dev. 2015 Jan 28;2:14059. doi: 10.1038/mtm.2014.59. eCollection 2015.
2
Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model.利用患者诱导多能干细胞衍生的神经干细胞进行体外基因治疗可逆转同源小鼠模型大脑中的病变。
Stem Cell Reports. 2015 May 12;4(5):835-46. doi: 10.1016/j.stemcr.2015.02.022. Epub 2015 Apr 9.
3
Accounting for undetected compounds in statistical analyses of mass spectrometry 'omic studies.
通过转录组学方法证实,黏多糖贮积症中参与代谢过程的蛋白质编码基因失调。
Metab Brain Dis. 2023 Aug;38(6):2133-2144. doi: 10.1007/s11011-023-01231-5. Epub 2023 May 17.
4
The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis.黏多糖贮积症中糖胺聚糖与半胱氨酸组织蛋白酶的相互作用
Biomedicines. 2023 Mar 7;11(3):810. doi: 10.3390/biomedicines11030810.
5
Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients.黏多糖贮积症患者成纤维细胞中长链非编码 RNA 的表达。
Genes (Basel). 2023 Jan 20;14(2):271. doi: 10.3390/genes14020271.
6
The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.黏多糖贮积症患者细胞病理学中的炎症——以免疫调节药物作为治疗方法
Front Pharmacol. 2022 May 13;13:863667. doi: 10.3389/fphar.2022.863667. eCollection 2022.
7
Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease.IVA型黏多糖贮积症:心血管疾病中的细胞外基质生物标志物
Front Cardiovasc Med. 2022 May 10;9:829111. doi: 10.3389/fcvm.2022.829111. eCollection 2022.
8
Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.基于质谱的神经退行性溶酶体贮积症蛋白质组学。
Mol Omics. 2022 May 11;18(4):256-278. doi: 10.1039/d2mo00004k.
9
THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.THAP1 通过调节溶酶体中的 ECM 降解来调节少突胶质细胞成熟。
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31). doi: 10.1073/pnas.2100862118.
10
Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.与细胞过程相关的转录组变化,特别是在黏多糖贮积症组的溶酶体贮积病中的细胞激活。
Int J Mol Sci. 2020 Apr 30;21(9):3194. doi: 10.3390/ijms21093194.
在质谱“组学”研究的统计分析中考虑未检测到的化合物。
Stat Appl Genet Mol Biol. 2013 Dec;12(6):703-22. doi: 10.1515/sagmb-2013-0021.
4
Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation.线粒体氧化磷酸化超复合物的结构及其稳定机制。
Biochim Biophys Acta. 2014 Apr;1837(4):418-26. doi: 10.1016/j.bbabio.2013.10.004. Epub 2013 Oct 30.
5
Integrated analysis of transcriptomic and proteomic data.转录组和蛋白质组数据的综合分析。
Curr Genomics. 2013 Apr;14(2):91-110. doi: 10.2174/1389202911314020003.
6
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.骨关节炎膝关节滑液的蛋白质组学分析:与关节组织转录组分析的比较
Arthritis Rheum. 2013 Apr;65(4):981-92. doi: 10.1002/art.37823.
7
A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve.联合蛋白质组学和转录组学方法显示三尖瓣和二叶式主动脉瓣患者胸主动脉瘤发展中的分子机制存在差异。
Mol Cell Proteomics. 2013 Feb;12(2):407-25. doi: 10.1074/mcp.M112.021873. Epub 2012 Nov 26.
8
OXPHOS mutations and neurodegeneration.OXPHOS 突变与神经退行性变。
EMBO J. 2013 Jan 9;32(1):9-29. doi: 10.1038/emboj.2012.300. Epub 2012 Nov 13.
9
Complement is dispensable for neurodegeneration in Niemann-Pick disease type C.补体对于尼曼-匹克病 C 型的神经退行性变是可有可无的。
J Neuroinflammation. 2012 Sep 17;9:216. doi: 10.1186/1742-2094-9-216.
10
The complement system: an unexpected role in synaptic pruning during development and disease.补体系统:在发育和疾病过程中突触修剪中的意外作用。
Annu Rev Neurosci. 2012;35:369-89. doi: 10.1146/annurev-neuro-061010-113810.